TriSalus Life Sciences (TLSI) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

TriSalus Life Sciences (TLSI) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

TriSalus Life Sciences

· TLSI

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

249.549 M

-4.64%

General

Market Cap: $261.69M
Enterprise Value: $243.29M
Shares Outstanding: 61,420,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 85.79%
Operating Margin: -67.68%
Net Profit Margin: -62.59%
FCF Margin: -66.34%
ROA: -45.18%
ROE: 273.71%
ROIC: -59.22%
Current Ratio: 5.35
Debt-to-Equity: 5.26
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.33
P/S: 5.66
P/FCF: —
P/B: 38.95
EV/EBITDA: -11.23

Growth

Rev 1Y: 53.41%
Rev 1Y Fwd Est: 17.64%
Rev 3Y (CAGR): 53.85%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $45.08M
Gross Margin: 85.79%
Operating Expenses: $69.18M
Operating Income: -$30.51M
Net Profit: -$28.21M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $46.29M
Working Capital: $48.57M
Total Assets: $62.45M
Net Debt: -$11.86M
Total Liabilities: $55.9M
Total Equity: $6.55M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$29.28M
Cash Flow from Investing: -$581K
Cash Flow from Financing: $85.08M
Free Cash Flow: -$29.9M
Capital Expenditures: $621K